Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

91 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q3 2024.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 106M shares of 791M outstanding shares and own 13.37% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (15.3M shares), JANUS HENDERSON GROUP PLC (12.3M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (9.72M shares), Rock Springs Capital Management LP (9.53M shares), MANGROVE PARTNERS IM, LLC (8.73M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.71M shares), MILLENNIUM MANAGEMENT LLC (5.39M shares), Frazier Life Sciences Management, L.P. (5.1M shares), 683 Capital Management, LLC (4.85M shares), and ALKEON CAPITAL MANAGEMENT LLC (4.7M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.